<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00893100</url>
  </required_header>
  <id_info>
    <org_study_id>724</org_study_id>
    <nct_id>NCT00893100</nct_id>
  </id_info>
  <brief_title>Evaluation of Pain Reduction After Hemorrhoidectomy With Use of Diltiazim Ointment 2%</brief_title>
  <official_title>Evaluation of Pain Reduction After Hemorrhoidectomy With Use of Diltiazim Ointment 2%</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of diltiazem ointment 2 percent in
      reducing pain after hemorrhoidectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain after hemorrhoidectomy remains a major postsurgical complication.Therefore pain
      management in patients is an important goal.Many studies have focused on surgical
      techniques,preoperative and postoperative regimes.We assessed a randomised double blind
      placebo-controlled trial to evaluate the effect of diltiazem ointment after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of Pain</measure>
    <time_frame>daily in one week</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Diltiazem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diltiazem</intervention_name>
    <description>2%,3 times daily</description>
    <arm_group_label>Diltiazem</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with grade 3 or 4 hemorrhoid who underwent Milligan-Morgan surgery.

        Exclusion Criteria:

          -  Patients with a history of heart disease, blood pressure, orthostatic hypertension,
             hemorrhoidal surgery,or those who had previous adverse effect from calcium channel
             blocker drugs and also those who were pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farshad Jalili, Resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sina Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sina General Hospital</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2009</study_first_submitted>
  <study_first_submitted_qc>May 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2009</study_first_posted>
  <last_update_submitted>May 2, 2009</last_update_submitted>
  <last_update_submitted_qc>May 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>Bagher Larijani</name_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diltiazem</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

